DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20181763

Treatment outcome of antiretroviral treatment naive HIV infected patients initiated on antiretroviral therapy in a tertiary care hospital in South India

Rajendra Prasad S., Subhash Chandra B. J.

Abstract


Background: About 2.1 million people are infected with HIV in India. Clinical profile of patients has evolved over a period of time in the Antiretroviral treatment (ART) era. This study was done to document the clinical presentation of patients in a tertiary care in Mysuru in Karnataka. The aim of the study was to follow the patients who were initiated on ART over a period of time and to know its effect on the clinical outcome and overall morbidity and mortality of the patients.

Methods: A prospective study of HIV positive patients who were initiated on ART was done regarding clinical profile and outcome over a period of one and a half to two years depending on when they were initiated on ART.

Results: Totally 183 patients were registered during the period, out of which 114 patients (62.29%) were males and the rest were females (37.70%). The commonest route of transmission was heterosexual route seen in 97.3% (178). Most (56.8%) of the patients were asymptomatic. The mean basal CD4 count was 162.70. The mean age of patients was 39.07. The mean BMI was 20.29. A 23.5% (43) had one or other side effects. Anemia (44.2%) was the most common side effects seen. There were 18 deaths (12.2%). A 39.34% (72) patients had opportunistic infections (OI), the commonest being tuberculosis 45(%).

Conclusions: It was concluded that patients with low CD4 count, low BMI were more prone for Opportunistic infections and death. Early initiation of ART can prevent such incidences and improve the quality of life of HIV positive patients.


Keywords


Anemia, CD4 count, HIV infections, Opportunistic infections and tuberculosis

Full Text:

PDF

References


UNAIDS. Joint United Nations Programme on HIV/AIDS. UNAIDS data 2017. UNAIDS: Geneva, Switzerland. 2017

World Health Organization. World Health Statistics 2016: Monitoring health for the SDGs. Geneva: World Health Organization; 2016. Available at : http://www.who.int/gho/publications/world_health_statistics/2016/en/.

National AIDS Control Organization. Ministry of Health and Family Welfare, Government of India: HIV estimates in India. 2004. Available at: http://naco.gov.in/sites/default/files/NACO%20ANNUAL%20REPORT%202016-17.pdf.

Center for Disease control and prevention. HHS/CDC Global AIDS program (GAP) in India. The GAP India Fact sheet. 2018. Available at: http:/www.Cdc.gov/nchstp/od/gap/countries/India.htm.

Sharma SK, Kadhiravan T, Banga A, Goyal T, Bhatia I, Saha PK. Spectrum of clinical disease in a series of 135 hospitalized HIV-infected patients from North India. BMC infectious Diseases. 2004;4:52.

Chakravarty J, Mehta H, Parekh A, Attili SV, Agrawal NR, Singh SP, Sundar S. Study on clinico-epidemiological profile of HIV patients in eastern India. JAPI. 2006;54:854-7.

Goel R, Rai M, Chakravarty J, Meena LP, Tiwary NK, Sundar S, Bharti A. Clinical profile and response to first-line ARV in HIV patients from eastern UP and Bihar: a retrospective study. J Association Physicians Ind. 2013;61(4):239-43.

Usmani MH, Qureishi R, Patel R, Kumar P. Clinical spectrum of opportunistic infections in HIV positive patients. JEMDS. 2015;4(24):4076-85.

Vaseem B. Madhushanker-A study of Socio demographic profile and risk factor present in HIV infected patients attending ART centre in tertiary care hospital in Rajasthan, India. National J Community Med. 2012;3(2).

Joge US, Deo DS, Lakde RN, Choudhari SG, Malkar VR, Ughade HH. Sociodemographic and clinical profile of HIV/AIDS patients visiting to ART Centre at a rural tertiary care hospital in Maharashtra state of India. Int J Biol Med Res. 2012;3(2):1568-72.

Sun J, Liu L, Shen J, Chen P, Lu H. Trends in baseline CD4 cell counts and risk factors for late antiretroviral therapy initiation among HIV-positive patients in Shanghai, a retrospective cross-sectional study. BMC infectious diseases. 2017;17(1):285.

Bacchetti P, Gripshover B, Grunfeld C, Heymsfield S, McCreath H, Osmond D, et al. Fat distribution in men with HIV infection. Journal of acquired immune deficiency syndromes (1999). 2005;40(2):121-31.

Crum-Cianflone N, Roediger MP, Eberly L, Headd M, Marconi V, Ganesan A, et al. Infectious Disease Clinical Research Program HIV Working Group. Increasing rates of obesity among HIV-infected persons during the HIV epidemic. Plos one. 2010;5(4):e10106.

Vajpayee M, Kanswal S, Seth P, Wig N. Spectrum of opportunistic infections and profile of CD4+ counts among AIDS patients in North India. Infection. 2003;31(5):336-40.

Tamir Z, Alemu J, Tsegaye A. Anemia among HIV infected individuals taking art with and without zidovudine at Addis Ababa, Ethiopia. Ethiopian J Heal Sci. 2018;28(1):73-82.

Chang CY, Schiano TD. Drug hepatotoxicity. Alimentary pharmacology and therapeutics. 2007;25(10):1135-51.

Zachariah R, Fitzgerald M, Massaquoi M, Pasulani O, Arnould L, Makombe S, et al. Risk factors for high early mortality in patients on antiretroviral treatment in a rural district of Malawi. AIDS. 2006;20(18):2355-60.

Palella Jr FJ, Armon C, Chmiel JS, Brooks JT, Hart R, Lichtenstein K, et al. CD4 cell count at initiation of ART, long-term likelihood of achieving CD4> 750 cells/mm3 and mortality risk. J Antimicrobial Chemotherapy. 2016;71(9):2654-62.

French AL, Gawel SH, Hershow R, Benning L, Hessol NA, Levine AM, et al. Trends in mortality and causes of death among women with HIV in the US: A ten-year study. J acquired immune deficiency syndromes (1999). 2009;51(4):399.

Bonnet F, Lewden C, May T, Heripret L, Jougla E, Bevilacqua S, et al. Mortalite 2000 Study Group. Opportunistic infections as causes of death in HIV-infected patients in the HAART era in France. Scandinavian J infec Dis. 2005;37(6-7):482-7.